UoB Benjamin Meaker Visiting Professor Louisa Degenhardt, National Drug and Alcohol Centre, UNSW Sydney, Australia

Louisa Degenhardt

Epidemiology of drug related harm – Global Burden of Disease and Lancet Commission

27th October - 24th November 2017

Professor Degenhardt is UNSW Scientia Professor of Epidemiology and NHMRC Principal Research Fellow at the National Drug and Alcohol Research Centre (NDARC) at UNSW.


Professor Degenhardt is internationally acknowledged for her research on the epidemiology of illicit drug use, morbidity and mortality. She is regularly sought by researchers, NGOs, and UN agencies to collaborate and provide advice. She is a member of the WHO’s Technical Advisory Group on Alcohol and Drug Epidemiology; is on the Core Analytic team for the ongoing Global Burden of Disease study led by IHME at the University of Washington in Seattle.

Her data linkage work on opioid dependence, treatment and mortality is used by health and corrective services departments in Australia and internationally to evaluate the benefits and risks of opioid dependence treatment. Her post-marketing surveillance work informed Pharmaceutical Benefits Advisory Committee decisions on listing of opioid medications on the Australian Pharmaceutical Benefits Scheme. 


Prof Louisa Degenhardt is one of the leading epidemiologists in addiction science in the world. Through her visit we aim to work with researchers at UoB in order to exploit and extend two global reviews of injecting drug use prevalence and burden and to develop plans for a new series of papers on substance use.

We will develop and progress further academic papers that exploit the systematic review data collected for the global reviews. Prof Degenhardt will work closely with Prof Vickerman and other researchers and PhD students within HPRU and others with an interest in global health and addiction.

In addition we propose a new series of papers in response to US Surgeon General’s report, Facing Addiction in America, which provided an unexpectedly candid overview of the extent of the drug problem in the United States and a balanced review of the evidence on the effectiveness of interventions to address it. Prof Degenhardt will work with infectious disease and mathematical modelers to translate evidence reviews into assessments of the effect of changes in drug policy. 

During her stay in Bristol, Professor Degenhardt will be hosted by Professor Matthew Hickman (Population Health Science).


Public Lecture
1 November, 16.15, Room LG.8-9, Canynge Hall

Global profile of people who inject drugs: systematic reviews of prevalence of injecting, key health harms and coverage of interventions

All welcome